Jason Hoffman, PharmD, RPh

Deciding not to intervene for small, incidentally identified thyroid cancer may cause patients to experience anxiety and feelings of isolation.

In patients with soft tissue sarcoma pretreated with doxorubicin, treatment with regorafenib significantly reduced the risk of progression symptoms or toxicity.

Universal screening of women with gynecologic malignancies for early palliative care decreased the use of aggressive measures at the end of life.

Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.

The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.

A study that integrated genomic and clinical data identified 3 distinct clusters of patients with serous epithelial ovarian cancer who do not respond to chemotherapy.

An enhanced recovery program is more cost-effective than usual care in patients undergoing primary cytoreductive surgery for ovarian cancer.

Rucaparib was active with an acceptable safety profile in patients with relapsed, platinum-sensitive high-grade ovarian carcinoma with germline or somatic BRCA mutations.

There was no additional protective effect with a third dose of the human papillomavirus vaccine compared with receiving only 2 doses of the vaccine.

A study of a large, diverse patient population appears to show an increasing incidence of lung cancer in patients who have never smoked tobacco.